Alto Neuroscience Inc.. (ANRO) NEW YORK STOCK EXCHANGE INC.
$13.41 (0.43) (-3.11%)
Market Cap: $372.07M
As of 05/16/24 11:55 AM EDT. Market open.
Alto Neuroscience Inc.. (ANRO)
NEW YORK STOCK EXCHANGE INC.
$13.41
(0.43) (-3.11%)
Market Cap: $372.07M
As of 05/16/24 11:55 AM EDT. Market open.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
URL
Address
.
PRICE CHART FOR ALTO NEUROSCIENCE INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$13.88
Previous Close
$13.84
Days Range
$13.69 - $14.70
52 week range
$12.78 - $24
Volume
22,363
Avg. Volume (30 days)
88,894
Market Cap
$372.07M
Dividend Yield
-
P/E
-
Shares Outstanding
26,883,990
Open
$13.88
Previous Close
$13.84
Days Range
$13.69 - $14.70
52 week range
$12.78 - $24
Volume
22,363
Avg. Volume (30 days)
88,894
Market Cap
$372.07M
Dividend Yield
-
P/E
-
Shares Outstanding
26,883,990
FINANCIAL STATEMENTS FOR ALTO NEUROSCIENCE INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ALTO NEUROSCIENCE INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Mar 28, 2024 | Buy | $16.36 | 6,150 | 100,628 | 26,866 | Apr 01, 2024, 04:15 PM |
| Alpha Wave Global, LP | 10% Owner | Feb 06, 2024 | Buy | $16.00 | 600,000 | 9,600,000 | 3,707,757 | Feb 08, 2024, 04:32 PM |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Feb 06, 2024 | Buy | $16.00 | 1,563 | 25,008 | 1,563 | Feb 07, 2024, 04:40 PM |
| Savitz Adam | CHIEF MEDICAL OFFICER | Feb 06, 2024 | Buy | $16.00 | 17,000 | 272,000 | 24,851 | Feb 07, 2024, 04:38 PM |
| Etkin Amit | PRESIDENT AND CEO | Feb 06, 2024 | Buy | $16.00 | 3,125 | 50,000 | 1,205,465 | Feb 07, 2024, 04:36 PM |
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | 03/28/2024 | 100,628 |
| Alpha Wave Global, LP | 10% Owner | 02/06/2024 | 9,600,000 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | 02/06/2024 | 25,008 |
| Savitz Adam | CHIEF MEDICAL OFFICER | 02/06/2024 | 272,000 |
| Etkin Amit | PRESIDENT AND CEO | 02/06/2024 | 50,000 |
FUNDS WITH A POSITION IN ALTO NEUROSCIENCE INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 1,385,491 | 0.27% | New | Other |
| BLACKROCK INC. | 141,568 | 0.00005% | New | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 86,141 | 0.00012% | New | Other |
BUYBACK ANNOUNCEMENT(S) FOR ALTO NEUROSCIENCE INC.
LOADING...